(Total Views: 135)
 Posted On: 02/20/2022 9:03:50 AM 
  
		  		    Post#  of 26280		    
			
		      
  
	$STAB News February 15, 2022 
 
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
 	
 
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
 (0)
(0) (0)
(0) 
      			












